journal article·2022-07Open access

A Print‐and‐Fuse Strategy for Sacrificial Filaments Enables Biomimetically Structured Perfusable Microvascular Networks with Functional Endothelium Inside 3D Hydrogels

Matthias Ryma, Hatice Genç, Ali Nadernezhad, Ilona Paulus, Dominik Schneidereit, Oliver Friedrich, Kristina Andelovic, Stefan Lyer, Christoph Alexiou, Iwona Cicha, Jürgen Groll

Advanced Materials· Volume 34· Issue 28

Abstract

Abstract A facile and flexible approach for the integration of biomimetically branched microvasculature within bulk hydrogels is presented. For this, sacrificial scaffolds of thermoresponsive poly(2‐cyclopropyl‐2‐oxazoline) (PcycloPrOx) are created using melt electrowriting (MEW) in an optimized and predictable way and subsequently placed into a customized bioreactor system, which is then filled with a hydrogel precursor solution. The aqueous environment above the lower critical solution temperature (LCST) of PcycloPrOx at 25 °C swells the polymer without dissolving it, resulting in fusion of filaments that are deposited onto each other (print‐and‐fuse approach). Accordingly, an adequate printing pathway design results in generating physiological‐like branchings and channel volumes that approximate Murray's law in the geometrical ratio between parent and daughter vessels. After gel formation, a temperature decrease below the LCST produces interconnected microchannels with distinct inlet and outlet regions. Initial placement of the sacrificial scaffolds in the bioreactors in a pre‐defined manner directly yields perfusable structures via leakage‐free fluid connections in a reproducible one‐step procedure. Using this approach, rapid formation of a tight and biologically functional endothelial layer, as assessed not only through fluorescent dye diffusion, but also by tumor necrosis factor alpha (TNF‐α) stimulation, is obtained within three days.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Additive Manufacturing and 3D Printing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chair for Functional Materials for Medicine and Dentistry at the Institute for Functional Materials and Biofabrication (IFB) and Bavarian Polymer Institute (BPI) University of Würzburg Pleicherwall 2 97070 Würzburg Germany

Section of Experimental Oncology and Nanomedicine (SEON) Else Kröner‐Fresenius‐Stiftung‐endowed Professorship for Nanomedicine ENT Department Universitätsklinikum Erlangen Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Glueckstr. 10a 91054 Erlangen Germany

Institute of Medical Biotechnology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Ulrich‐Schalk‐Str. 3 91056 Erlangen Germany

(Chair of) Experimental Biomedicine II University Hospital Würzburg Josef‐Schneider‐Straße 2 97080 Würzburg Germany

Funding

Deutsche Forschungsgemeinschaft

References (53)

Show source-provided references
1. 10.1242/jcs.07950910.1242/jcs.079509 ↗
2. 10.1152/physiol.00036.201610.1152/physiol.00036.2016 ↗
3. 10.1557/mrc.2017.5810.1557/mrc.2017.58 ↗
4. 10.1098/rsif.2013.112410.1098/rsif.2013.1124 ↗
5. 10.1038/s41536-017-0011-610.1038/s41536-017-0011-6 ↗
6. 10.1088/2516-1091/ab563710.1088/2516-1091/ab5637 ↗
7. 10.1186/s12938-020-0752-010.1186/s12938-020-0752-0 ↗
8. 10.1038/nmat86310.1038/nmat863 ↗
9. 10.1126/sciadv.150075810.1126/sciadv.1500758 ↗
10. 10.1002/term.163510.1002/term.1635 ↗
11. 10.1038/s41578-018-0006-y10.1038/s41578-018-0006-y ↗
12. 10.1002/adma.20100462510.1002/adma.201004625 ↗
13. 10.1073/pnas.152134211310.1073/pnas.1521342113 ↗
14. 10.1126/sciadv.aaw245910.1126/sciadv.aaw2459 ↗
15. 10.1039/C8RA03022G10.1039/C8RA03022G ↗
16. 10.1016/j.addma.2018.04.02610.1016/j.addma.2018.04.026 ↗
17. 10.1038/nmat335710.1038/nmat3357 ↗
18. 10.1016/j.addma.2018.12.01410.1016/j.addma.2018.12.014 ↗
19. 10.1016/j.polymer.2014.08.02410.1016/j.polymer.2014.08.024 ↗
20. 10.1016/j.matdes.2018.03.05310.1016/j.matdes.2018.03.053 ↗
21. 10.1002/smll.20180023210.1002/smll.201800232 ↗
22. 10.1088/1758-5090/7/3/03500210.1088/1758-5090/7/3/035002 ↗
23. 10.1016/j.atherosclerosis.2009.04.03410.1016/j.atherosclerosis.2009.04.034 ↗
24. 10.1160/TH13-11-090810.1160/TH13-11-0908 ↗
25. 10.1002/admt.20210022110.1002/admt.202100221 ↗
26. 10.1002/adfm.20190466410.1002/adfm.201904664 ↗
27. 10.1002/adma.20130550610.1002/adma.201305506 ↗
28. 10.1016/j.eurpolymj.2016.09.05210.1016/j.eurpolymj.2016.09.052 ↗
29. 10.1021/ma200514n10.1021/ma200514n ↗
30. 10.1073/pnas.12.3.20710.1073/pnas.12.3.207 ↗
31. 10.1122/1.493424010.1122/1.4934240 ↗
32. 10.1002/dvdy.1011910.1002/dvdy.10119 ↗
33. Kurz H. · Comments Theor. Biol. · 1997 · 4 · 261
34. Aird W. C. · Pharmacol. Rep. · 2008 · 60 · 139
35. 10.1007/s00424000030710.1007/s004240000307 ↗
36. 10.1016/S0008-6363(96)00064-810.1016/S0008-6363(96)00064-8 ↗
37. 10.1038/srep0193210.1038/srep01932 ↗
38. 10.1002/jemt.1008610.1002/jemt.10086 ↗
39. 10.1097/01.CCM.0000129669.21649.4010.1097/01.CCM.0000129669.21649.40 ↗
40. Urschel K. · Int. J. Interferon, Cytokine Mediator Res. · 2015 · 7 · 9
41. 10.1182/blood-2006-05-02087510.1182/blood-2006-05-020875 ↗
42. 10.3233/CH-2010-134610.3233/CH-2010-1346 ↗
43. 10.1002/mrm.109610.1002/mrm.1096 ↗
44. 10.3389/fnins.2020.0041510.3389/fnins.2020.00415 ↗
45. Papaioannou T. G. · Hell. J Cardiol. · 2005 · 46 · 9
46. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
47. 10.1007/s10439-008-9531-y10.1007/s10439-008-9531-y ↗
48. 10.1016/j.jmbbm.2021.10502410.1016/j.jmbbm.2021.105024 ↗
49. 10.1152/ajpheart.1992.263.6.H177010.1152/ajpheart.1992.263.6.H1770 ↗
50. 10.1016/j.atherosclerosis.2007.03.01610.1016/j.atherosclerosis.2007.03.016 ↗
51. 10.1038/s41377-018-0080-310.1038/s41377-018-0080-3 ↗
52. 10.1093/bioinformatics/btp18410.1093/bioinformatics/btp184 ↗
53. 10.3233/CH-2010-134610.3233/CH-2010-1346 ↗